Testing Blood For Circulating Tumor Cells Helps Inform Clinical Decisions About Treat

[News]

Researchers at Georgetown Lombardi Comprehensive Cancer Center say the number of circulating tumor cells (CTCs) in the blood is a "powerful predictor" to help physicians more reliably assess treatment benefit for patients with metastatic breast cancer...

More... (http://www.medicalnewstoday.com/releases/225822.php)